Overview
Innovative drug screening and design driven by AI and silicon-based peptide chips
Funding
USD estimates from the source recordListed 1 funding record. Latest funding: $714K (战略投资), Jul 1, 2025.
Annual trendUnit: USD estimate
| Date | Amount | Investors | Source |
|---|---|---|---|
| Jul 1, 2025 | $714K | Hanyuyaoye |
Valuation
USD estimates from the source recordListed 1 valuation record.
Annual trendUnit: USD estimate
No chartable valuation estimates yet.
1 listed record lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Source |
|---|---|---|---|
| Jul 1, 2025 | — | Hanyuyaoye |
Revenue
USD estimates from the source recordNo revenue records are listed yet.
Annual trendUnit: USD estimate
No chartable revenue estimates yet.
No revenue rows to list.
Team, products & investors
Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
AI 与硅基多肽芯片驱动的创新药物筛选与设计